Viatronix Incorporated, a Stony Brook, New York, based company announced that its V3D-Colon software is used at the National Naval Medical Center where the President's annual physical was done. "Our software is being utilized at several DOD facilities since the landmark Virtual Colonoscopy clinical trial published in the New England Journal of Medicine back in December 2003," said Zaffar Hayat, President of Viatronix Incorporated.

Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl® LP 22...

As a complimentary service, Market Street pharmacies are expanding the grocer’s whole-health commitment to its guests by offering free antibiotics and prenatal vitamins to North Texans to help weather the cold and flu season through its “Free to Feel Better” program. Additionally, Market Street’s new partnership with Dallas-based MedicalEdge has transformed the Living Well ExpressCare Centers into more than just walk-in clinics.

A new candidate gene for Specific Language Impairment (SLI) has been identified by a research team directed by Mabel Rice from the University of Kansas, in collaboration with Shelley Smith, University of Nebraska Medical Center, and Javier Gayán of Neocodex, Seville, Spain.

Vetericyn Inc., a California-based animal healthcare company, has announced the launch of its new Vetericyn™ equine product, available in a 16-ounce trigger spray for horses. Vetericyn™ utilizes an FDA-cleared technology that has been used to successfully treat over one million human patients without a single serious adverse effect. Now, the innovative topical wound-care product is available to the animal healthcare market.

Novasys Medical, Inc., a developer of innovative therapies in women's health, announced that as of July 1, 2009, First Coast Service Options, Inc. ("First Coast"), a large regional Medicare carrier serving over 3 million beneficiaries in Florida, Puerto Rico and the U.S.

The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.

Writing in a leading medical journal, the Health Commissioner for the City of New York argues in support of taxing sweetened beverages, suggesting that a "penny per ounce" excise tax could reduce their consumption by more than ten per cent, a much bigger change than could be achieved by education alone, in the fight to tackle the rising problem of obesity.